These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 38158956)

  • 1. [Tuberculosis infection in patients with inflammatory bowel diseases. Clinacal cases].
    Timanovskaia MU; Shaykhtdinova YR; Zhulina EU; Kulakov DS; Kagramanova AV; Knyzev OV; Parfenov AI
    Ter Arkh; 2023 Dec; 95(11):979-984. PubMed ID: 38158956
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Latent and Active Tuberculosis Infection in Patients with Inflammatory Bowel Disease].
    Jin BC; Moon HJ; Kim SW
    Korean J Gastroenterol; 2022 Aug; 80(2):72-76. PubMed ID: 36004634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recommendations of the Spanish Working Group on Crohn's Disease and Ulcerative Colitis (GETECCU) on screening and treatment of tuberculosis infection in patients with inflammatory bowel disease.
    Riestra S; Taxonera C; Zabana Y; Carpio D; Beltrán B; Mañosa M; Gutiérrez A; Barreiro-de Acosta M
    Gastroenterol Hepatol; 2021 Jan; 44(1):51-66. PubMed ID: 32828562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of a prodromal period in Crohn's disease but not ulcerative colitis.
    Pimentel M; Chang M; Chow EJ; Tabibzadeh S; Kirit-Kiriak V; Targan SR; Lin HC
    Am J Gastroenterol; 2000 Dec; 95(12):3458-62. PubMed ID: 11151877
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interferon alpha (IFN alpha 2a) therapy for herpes virus-associated inflammatory bowel disease (ulcerative colitis and Crohn's disease).
    Ruther U; Nunnensiek C; Muller HA; Bader H; May U; Jipp P
    Hepatogastroenterology; 1998; 45(21):691-9. PubMed ID: 9684118
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Contrasting Pattern of Chronic Inflammatory Bowel Disease in Primary and Autoimmune Sclerosing Cholangitis.
    Bjarnason I; Hayee B; Pavlidis P; Kvasnovsky C; Scalori A; Sisson G; Charlesworth A; Shaikh H; Bjornsson E; Heneghan MA
    EBioMedicine; 2015 Oct; 2(10):1523-7. PubMed ID: 26629548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Extraintestinal manifestations in inflammatory bowel disease: differences between Crohn's disease and ulcerative colitis].
    Rubio-Nazábal E; Alvarez-Pérez P; López-Facal M; Fernández-Couto D
    Med Clin (Barc); 2006 Apr; 126(13):517-8. PubMed ID: 16624238
    [No Abstract]   [Full Text] [Related]  

  • 8. The safety of vedolizumab in a patient with Crohn's disease who developed anti-TNF-alpha agent associated latent tuberculosis infection reactivation: A case report.
    Sugiyama Y; Ueno N; Tachibana S; Kobayashi Y; Murakami Y; Sasaki T; Sakatani A; Takahashi K; Ando K; Kashima S; Moriichi K; Tanabe H; Okumura T; Fujiya M
    Medicine (Baltimore); 2023 Jul; 102(28):e34331. PubMed ID: 37443475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anemia in inflammatory bowel disease: prevalence, differential diagnosis and association with clinical and laboratory variables.
    Alves RA; Miszputen SJ; Figueiredo MS
    Sao Paulo Med J; 2014; 132(3):140-6. PubMed ID: 24760213
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognosticating the Course of Inflammatory Bowel Disease.
    Koliani-Pace JL; Siegel CA
    Gastrointest Endosc Clin N Am; 2019 Jul; 29(3):395-404. PubMed ID: 31078243
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes of Treatment for Latent Tuberculosis Infection in Patients With Inflammatory Bowel Disease Receiving Biologic Therapy.
    Ramos GP; Stroh G; Al-Bawardy B; Faubion WA; Papadakis KA; Escalante P
    Inflamm Bowel Dis; 2018 Sep; 24(10):2272-2277. PubMed ID: 29718223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Stringent screening strategy significantly reduces reactivation rates of tuberculosis in patients with inflammatory bowel disease on anti-TNF therapy in tuberculosis endemic region.
    Kumar P; Vuyyuru SK; Kante B; Sahu P; Goyal S; Madhu D; Jain S; Ranjan MK; Mundhra S; Golla R; Singh M; Virmani S; Gupta A; Yadav N; Kalaivani M; Sharma R; Das P; Makharia G; Kedia S; Ahuja V
    Aliment Pharmacol Ther; 2022 Jun; 55(11):1431-1440. PubMed ID: 35229906
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tissue IgG4-positive plasma cells in inflammatory bowel disease: a study of 88 treatment-naive biopsies of inflammatory bowel disease.
    Virk R; Shinagare S; Lauwers GY; Yajnik V; Stone JH; Deshpande V
    Mod Pathol; 2014 Mar; 27(3):454-9. PubMed ID: 23929268
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inflammatory bowel disease.
    Beattie RM; Croft NM; Fell JM; Afzal NA; Heuschkel RB
    Arch Dis Child; 2006 May; 91(5):426-32. PubMed ID: 16632672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Negative Screening Does Not Rule Out the Risk of Tuberculosis in Patients with Inflammatory Bowel Disease Undergoing Anti-TNF Treatment: A Descriptive Study on the GETAID Cohort.
    Abitbol Y; Laharie D; Cosnes J; Allez M; Nancey S; Amiot A; Aubourg A; Fumery M; Altwegg R; Michetti P; Chanteloup E; Seksik P; Baudry C; Flamant M; Bouguen G; Stefanescu C; Bourrier A; Bommelaer G; Dib N; Bigard MA; Viennot S; Hébuterne X; Gornet JM; Marteau P; Bouhnik Y; Abitbol V; Nahon S;
    J Crohns Colitis; 2016 Oct; 10(10):1179-85. PubMed ID: 27402916
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Extraintestinal manifestations in inflammatory bowel disease].
    Vavricka SR
    Ther Umsch; 2023 Dec; 80(9):393-397. PubMed ID: 38095252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Significant risk and associated factors of active tuberculosis infection in Korean patients with inflammatory bowel disease using anti-TNF agents.
    Kim ES; Song GA; Cho KB; Park KS; Kim KO; Jang BI; Kim EY; Jeon SW; Lee HS; Yang CH; Lee YK; Lee DW; Kim SK; Kim TO; Lee J; Kim HW; Jee SR; Park SJ; Kim HJ
    World J Gastroenterol; 2015 Mar; 21(11):3308-16. PubMed ID: 25805938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with psoriasis are more likely to be treated for latent tuberculosis infection prior to biologics than patients with inflammatory bowel disease.
    Bassukas ID; Kosmidou M; Gaitanis G; Tsiouri G; Tsianos E
    Acta Derm Venereol; 2011 Jun; 91(4):444-6. PubMed ID: 21547342
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Magnetic resonance imaging to distinguish the type and severity of pediatric inflammatory bowel diseases.
    Durno CA; Sherman P; Williams T; Shuckett B; Dupuis A; Griffiths AM
    J Pediatr Gastroenterol Nutr; 2000 Feb; 30(2):170-4. PubMed ID: 10697136
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic yield of capsule endoscopy in ulcerative colitis and inflammatory bowel disease of unclassified type (IBDU).
    Mehdizadeh S; Chen G; Enayati PJ; Cheng DW; Han NJ; Shaye OA; Ippoliti A; Vasiliauskas EA; Lo SK; Papadakis KA
    Endoscopy; 2008 Jan; 40(1):30-5. PubMed ID: 18058654
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.